The National Methamphetamine
Drug Conference
This report is based upon presentations and discussions at the National Methamphetamine Drug Conference held at the Red Lion Hotel, May 28–30, 1997, in Omaha, Nebraska. All remarks were edited for clarity. It is our hope that we accurately captured each speaker's intent. Any errors or omissions in content are entirely the fault of the editorial staff.
The remarks attributed to speakers do not necessarily reflect the opinions or official policy of the agencies they represent.
In this report, the term "meth" is used interchangeably with methamphetamine.
All material in this report is in the public domain and may be duplicated without permission from the Office of National Drug Control Policy. Citation of the source is appreciated.
The Office of National Drug Control Policy acknowledges the generous funding given by the University of Nebraska Medical Center (UNMC). The mission of the Medical Center is to improve health in Nebraska through premier educational programs, innovative research, quality patient care, and outreach to underserved populations. Additionally, ONDCP extends its appreciation to UNMC for providing workgroup facilitators, recorders, and administrative staff.
Printed 1997
This document was prepared entirely by ONDCP staff. Any questions about its content should be directed to ONDCP, Bureau of State and Local Affairs, 750 17th Street N.W., Washington, D.C. 20503.
